Home › Compare › AEDC vs MRK

AEDC vs MRK: Dividend Comparison 2026

AEDC yields 100000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AEDC wins by $4.832206901976048e+26M in total portfolio value
10 years
AEDC
AEDC
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full AEDC calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — AEDC vs MRK

📍 AEDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAEDCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AEDC + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AEDC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AEDC
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, AEDC beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AEDC + MRK for your $10,000?

AEDC: 50%MRK: 50%
100% MRK50/50100% AEDC
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AEDC
No analyst data
Altman Z
432.8
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AEDC buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAEDCMRK
Forward yield100000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.832206901976048e+26M$30.7K ✓
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00 ✓$950.29
Total dividends collected$4.8315851896727036e+26M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AEDC vs MRK ($10,000, DRIP)

YearAEDC PortfolioAEDC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,010,700$10,000,000.00$11,192$351.54+$10.00M → AEDC
2$9,366,505,842$9,355,794,392.52$12,524$392.70+$9366.49M → AEDC
3$8,191,091,111,834$8,181,068,950,583.78$14,015$438.65+$8191091.10M → AEDC
4$6,695,134,751,499,451$6,686,370,284,009,789.00$15,682$489.96+$6695134751.48M → AEDC
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$17,547$547.23+$5114850040116.01M → AEDC
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$19,632$611.16+$3652290278277141.00M → AEDC
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$21,963$682.53+$2437583176648375296.00M → AEDC
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$24,571$762.18+$1.5206125080790106e+21M → AEDC
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$27,486$851.08+$8.866373796011065e+23M → AEDC
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$30,745$950.29+$4.832206901976048e+26M → AEDC

AEDC vs MRK: Complete Analysis 2026

AEDC — Stock

American Energy Development Corp. operates as an independent energy company, develops oil and gas basins in the United States. It holds interest in Dansville prospects that consist of 1,343 acre located in Ingham County, Michigan. The company was formerly known as LJM Energy Corp. and changed its name to American Energy Development Corp. in July 2011. American Energy Development Corp. was founded in 2010 and is based in New York, New York.

Full AEDC Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this AEDC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AEDC vs SCHDAEDC vs JEPIAEDC vs OAEDC vs KOAEDC vs MAINAEDC vs JNJAEDC vs ABBVAEDC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.